Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Financial Results for the quarter and financial year ended on March 31, 2024.15-05-2024
15-05-2024
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
The Board of Directors of the Company at its meeting held today i.e. May 15, 2024 has inter alia consider and approved the increase in Authorized Share Capital of the Company.15-05-2024
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Qualified Institutional Placement
Raising of Funds by issuance of such number of Equity Shares having face value of Re. 1 each of the Company (Equity Shares) and/or other eligible securities or any combination thereof, or an aggregate amount not exceeding Rs. 7,500 Crore or an equivalent amount thereof by way of issuance of Equity/Equity linked securities under Qualified Institutional Placement or through issuance of FCCBs, ADRs/ GDRs/ Debt Securities or through any permissible mode.15-05-2024
Mankind Pharma Ltd - 543904 - Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').
The Board of Directors of the Company at its meeting held today i.e. May 15 2024, has inter alia consider and approve the: 8. Re-appointment of M/s M. K. Kulshrestha & Associates, Cost Accountants as the Cost Auditors of the Company for the Financial Year 2024-25. 9. Re-appointment of M/s Dayal & Maur, Company Secretaries as the Secretarial Auditors of the Company for the Financial Year 2024-25.15-05-2024
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
The Board of Directors of the Company at its meeting held today i.e. May 15, 2024 has inter alia consider and approved the following: 7. Re-appointment of M/s S. R. Batliboi & Co. LLP, Chartered Accountants (Firm Registration No: 301003E/E300005 as Joint Statutory Auditors.15-05-2024
Mankind Pharma Q4 Results: Profit Rises 62.3%, Beats Estimates
The pharma company's net profit rose 62.3% year-on-year to Rs 477 crore in the January-March quarter.15-05-2024
Mankind Pharma Ltd - 543904 - Board Meeting Outcome for Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').
Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations').15-05-2024
Mankind Pharma Ltd - 543904 - Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').
Outcome of Board Meeting held today i.e. May 15, 202415-05-2024
Mankind Pharma Ltd - 543904 - Clarification sought from Mankind Pharma Ltd
The Exchange has sought clarification from Mankind Pharma Ltd on May 15, 2024, with reference to news appeared in www.business-standard.com dated May 15, 2024 quoting "Mankind Pharma in fray to acquire Advents stake in Bharat Serums " The reply is awaited.15-05-2024
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 46698 equity shares under Mankind Pharma Limited Employee Stock Option Plan 202210-05-2024